Zacks Investment Research on MSN
Silence Therapeutics (SLN) upgraded to buy: Here's why
Silence Therapeutics PLC Sponsored ADR (SLN) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend ...
The Government of New Caledonia issued unanimously the export authorisations for Société Le Nickel up to 2 million tons of nickel ore, which brings its annual export authorisation up to 6 million tons ...
BMO Capital Markets said it views BioMarin Pharmaceutical (NASDAQ:BMRN), Legend Biotech (NASDAQ:LEGN) and Silence Therapeutics (NASDAQ:SLN) as attractive takeover targets following Eli Lilly’s (LLY) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results